You are here

  • Home
  • Archive
  • Volume 71, Issue 9
  • Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease

Article metrics

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease

 

Online download statistics by month:

Online download statistics by month: April 2022 to February 2023

AbstractFullPdf
Apr 20224913306195
May 202217799666
Jun 2022140311658
Jul 20226376239
Aug 20222402211116
Sep 202288011255
Oct 20228698754
Nov 20226957544
Dec 20223523619
Jan 20234753725
Feb 20235194322
Total149241181693